Publications - Publikationer https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Bcontroller%5D=Publications&cHash=9546217a4ac00b007ae5e1c6cbc8cb89 en-us PURE Extension typo3support@science.au.dk (Web Department) 30 <![CDATA[Enantiomer-Specific Cardiovascular Effects of the Ketone Body 3-Hydroxybutyrate]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=b5468f33-d70d-4e6b-aa2c-2253001e1203&tx_pure_pure5%5BshowType%5D=pub&cHash=41d787a34b8d2d51e0a1808ec627eff6 Gopalasingam, N., Moeslund, N., Christensen, K. H., et al. BACKGROUND: The ketone body 3-hydroxybutyrate (3-OHB) increases cardiac output (CO) by 35% to 40% in healthy people and people with heart failure. The mechanisms underlying the effects of 3-OHB on myocardial contractility and loading conditions as well as the cardiovascular effects of its enantiomeric forms, D-3-OHB and L-3-OHB, remain undetermined.

METHODS AND RESULTS: Three groups of 8 pigs each underwent a randomized, crossover study. The groups received 3-hour infusions of either D/L-3-OHB (racemic mixture), 100% L-3-OHB, 100% D-3-OHB, versus an isovolumic control. The animals were monitored with pulmonary artery catheter, left ventricle pressure-volume catheter, and arterial and coronary sinus blood samples. Myocardial biopsies were evaluated with high-resolution respirometry, coronary arteries with isometric myography, and myocardial kinetics with D-[11C]3-OHB and L-[11C]3-OHB positron emission tomography. All three 3-OHB infusions increased 3-OHB levels (P<0.001). D/L-3-OHB and L-3-OHB increased CO by 2.7 L/min (P<0.003). D-3-OHB increased CO nonsignificantly (P=0.2). Circulating 3-OHB levels correlated with CO for both enantiomers (P<0.001). The CO increase was mediated through arterial elastance (afterload) reduction, whereas contractility and preload were unchanged. Ex vivo, D- and L-3-OHB dilated coronary arteries equally. The mitochondrial respiratory capacity remained unaffected. The myocardial 3-OHB extraction increased only during the D- and D/L-3-OHB infusions. D-[11C]3-OHB showed rapid cardiac uptake and metabolism, whereas L-[11C]3-OHB demonstrated much slower pharmacokinetics.

CONCLUSIONS: 3-OHB increased CO by reducing afterload. L-3-OHB exerted a stronger hemodynamic response than D-3-OHB due to higher circulating 3-OHB levels. There was a dissocitation between the myocardial metabolism and hemodynamic effects of the enantiomers, highlighting L-3-OHB as a potent cardiovascular agent with strong hemodynamic effects.

]]>
Forskning Mon, 01 Apr 2024 11:42:50 +0200 b5468f33-d70d-4e6b-aa2c-2253001e1203
<![CDATA[Therapeutic Drug Monitoring for Tyrosine Kinase Inhibitors in Metastatic Renal Cell Carcinoma]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=a47fd84d-41f7-4d1e-b1ee-b7bb580c1bf7&tx_pure_pure5%5BshowType%5D=pub&cHash=ef0bfb0f7bf9dd8bcf17c4af78d1bf50 Henriksen, J. N., Andersen, C. U., Fristrup, N. Inter-individual variability in drug response pose significant challenges to treatment with tyrosine kinase inhibitors (TKIs) in patients with metastatic renal cell carcinoma (mRCC). TKIs meet traditional criteria for using therapeutic drug monitoring (TDM), but research is still limited. Understanding the role of TDM in individualizing treatment strategies could help optimize treatment. Here we review the state of knowledge of TDM for TKIs in mRCC treatment. A comprehensive literature review of original research studies focusing on TDM of TKIs in mRCC treatment, clinical in vivo studies reporting on pharmacokinetics-pharmacodynamics, therapeutic ranges, drug concentrations, dose adjustments, clinical outcomes, or other relevant aspects related to TDM. We reviewed studies involving human subjects published in peer-reviewed journals. A narrative synthesis approach was employed to summarize the findings. Key themes and trends related to TDM of TKIs in mRCC treatment were identified and synthesized to provide a comprehensive overview of the current state of knowledge. Our search yielded 25 articles. Most were observational. The most consistently reported association between plasma concentration and effect was pazopanib Ctrough >20 µg/mL, but this concentration was not significant across all studies. We found inconsistent evidence for sunitinib and cabozantinib. For axitinib, we found a clear exposure-response relationship, but research was too diverse to conclude on a therapeutic window to use for TDM. We found much heterogeneity between recommended time of measurement (minimum plasma concentration [Cmin], maximal plasma concentration [Cmax], area under the curve [AUC]) and large variation in plasma concentration associated with clinical outcomes, which makes it difficult to recommend specific concentration intervals based on 1 or more of these measurements. Results were more consistent with TKIs continuously administered. Further research is needed to elucidate the long-term impact of TDM to possibly establish standardized therapeutic intervals. Prospective studies are suggested. The application of TDM in TKI-combination therapy is warranted in future research.

]]>
Forskning Sat, 01 Jun 2024 11:42:50 +0200 a47fd84d-41f7-4d1e-b1ee-b7bb580c1bf7
<![CDATA[Case report]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=a6f4d1bc-23dd-43f2-86f7-92fd9cb9c5dd&tx_pure_pure5%5BshowType%5D=pub&cHash=7e12784487c9daba9afcb6af11b5f207 Jakobsen, S. R., Diaz-delCastillo, M., Jensen, M. B., Andersen, T. L., Eldrup, E., Nielsen, T. S. In this forensic case report, we present autopsy findings from a young male in his thirties who had been self-injecting paraffin oil into his upper extremities 8 years prior to death. The injections induced an inflammatory response, leading to granuloma formation. This, in turn, resulted in severe hypercalcemia. The external autopsy examination revealed gross macroscopic ulcerations and enlargement of upper extremities, while calcifications of ligaments, heart, kidneys and dura mater was revealed on postmortem CT-scans. Histopathological examination showed extensive multiorgan metastatic calcifications in several tissues including the lungs, heart and kidney. Cause of death was estimated to be the extensive calcific deposits in the heart likely resulting in cardiac arrest. To our knowledge this is the first case reporting findings from an autopsy in which the cause of death was linked to cosmetic oil injections.

]]>
Forskning Fri, 01 Mar 2024 11:42:50 +0100 a6f4d1bc-23dd-43f2-86f7-92fd9cb9c5dd
<![CDATA[Bone marrow adipocytes provide early sign for progression from MGUS to multiple myeloma]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=d0dec891-6cd2-4f77-9688-9ca5dcdd7f05&tx_pure_pure5%5BshowType%5D=pub&cHash=fb6b6a0a6a03b644b3e9d4720c4ece16 El-Masri, B. M., Leka, B., Mustapha, F., et al. Multiple Myeloma (MM) is the second most common hematological malignancy and is characterized by clonal expansion of malignant plasma cells in the bone marrow. In spite of recent advances in the field of MM, the disease has remained incurable. MM is preceded by a premalignant state known as monoclonal gammopathy of undetermined significance (MGUS), with a risk of progression to MM of 1% per year. Establishing a scalable approach that refines the identification of MGUS patients at high risk of progression to MM can transform the clinical management of the disease, improve the patient's quality of life, and will have significant socioeconomic implications. Here, we provide evidence that changes in the bone marrow adipose tissue (BMAT) provide an early sign for progression from MGUS to MM. We employed AI-assisted histological analysis of unstained bone marrow biopsies from MGUS subjects with or without progression to MM within 10 years (n = 24, n = 17 respectively). Although the BMAT fraction was not different between the two groups, bone marrow adipocyte (BMAd) density was decreased in MGUS patients who developed MM, compared to non-progressing MGUS patients. Importantly, the distribution profile for BMAd size and roundness was significantly different between the two groups, indicating a shift toward increased BMAd size and roundness in MGUS patients who developed MM. These early changes in the BMAT could serve as valuable early indicators for the transition from MGUS to MM, potentially enabling timely interventions and personalized treatment strategies. Finally, the AI-based approach for histological characterization of unstained bone marrow biopsies is cost-effective and fast, rendering its clinical implementation feasible.

]]>
Forskning Mon, 01 Jan 2024 11:42:50 +0100 d0dec891-6cd2-4f77-9688-9ca5dcdd7f05
<![CDATA[Serotonin Signaling through Lipid Membranes]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=1bffb63a-cf2b-4c26-b2b1-e8ff6a643796&tx_pure_pure5%5BshowType%5D=pub&cHash=889dbb2c428310fa34f17f51c815e197 Kalinichenko, L. S., Kornhuber, J., Sinning, S., Haase, J., Müller, C. P. Serotonin (5-HT) is a vital modulatory neurotransmitter responsible for regulating most behaviors in the brain. An inefficient 5-HT synaptic function is often linked to various mental disorders. Primarily, membrane proteins controlling the expression and activity of 5-HT synthesis, storage, release, receptor activation, and inactivation are critical to 5-HT signaling in synaptic and extra-synaptic sites. Moreover, these signals represent information transmission across membranes. Although the lipid membrane environment is often viewed as fairly stable, emerging research suggests significant functional lipid-protein interactions with many synaptic 5-HT proteins. These protein-lipid interactions extend to almost all the primary lipid classes that form the plasma membrane. Collectively, these lipid classes and lipid-protein interactions affect 5-HT synaptic efficacy at the synapse. The highly dynamic lipid composition of synaptic membranes suggests that these lipids and their interactions with proteins may contribute to the plasticity of the 5-HT synapse. Therefore, this broader protein-lipid model of the 5-HT synapse necessitates a reconsideration of 5-HT’s role in various associated mental disorders.

]]>
Forskning Mon, 01 Apr 2024 11:42:50 +0200 1bffb63a-cf2b-4c26-b2b1-e8ff6a643796
<![CDATA[5-HT_FAsTR]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=2e9523ab-d71f-48cb-a982-b82ed9ce2e9d&tx_pure_pure5%5BshowType%5D=pub&cHash=a6fff7909c730ed18d03a21a898f2e6f Bukowski, L., Strøm, M. E., Andersen, J. L., Maesen, J. B., Tian, L., Sinning, S. The neurotransmitter serotonin plays a pivotal role in mood and depression. It also acts as a vasoconstrictor within blood vessels and is the main neurotransmitter in the gastrointestinal system. In neurotransmission, released serotonin is taken up by serotonin transporters, which are principal targets of antidepressants and the psychostimulant, ecstasy. The investigation of serotonin transporters have relied almost exclusively on the use of radiolabeled serotonin in heterogenous end-point assays. Here we adapt the genetically encoded fluorescent biosensor, iSeroSnFR, to establish and validate the Serotonin (5-HT) Fluorescence Assay for Transport and Release (5-HT_FAsTR) for functional and pharmacological studies of serotonin transport and release. We demonstrate the applicability of the method for the study of a neuronal, high-affinity, low-capacity serotonin transporter (SERT) as well as an extraneuronal low-affinity, high-capacity organic cation transporter and mutants thereof. 5HT_FAsTR offers an accessible, versatile and reliable semi-homogenous assay format that only relies on a fluorescence plate reader for repeated, real-time measurements of serotonin influx and efflux. 5HT_FAsTR accelerates and democratizes functional characterization and pharmacological studies of serotonin transporters and genetic variants thereof in disease states such as depression, anxiety and ADHD.

]]>
Forskning Fri, 01 Mar 2024 11:42:50 +0100 2e9523ab-d71f-48cb-a982-b82ed9ce2e9d
<![CDATA[How osteons form]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=02f2ccc4-524a-4028-9c9c-02da42f62fa0&tx_pure_pure5%5BshowType%5D=pub&cHash=0dadff9dee8b6966197017f2b834acbf Hegarty-Cremer, S. G.D., Borggaard, X. G., Andreasen, C. M., et al. Osteon morphology provides valuable information about the interplay between different processes involved in bone remodelling. The correct quantitative interpretation of these morphological features is challenging due to the complexity of interactions between osteoblast behaviour, and the evolving geometry of cortical pores during pore closing. We present a combined experimental and mathematical modelling study to provide insights into bone formation mechanisms during cortical bone remodelling based on histological cross-sections of quiescent human osteons and hypothesis-testing analyses. We introduce wall thickness asymmetry as a measure of the local asymmetry of bone formation within an osteon and examine the frequency distribution of wall thickness asymmetry in cortical osteons from human iliac crest bone samples from women 16–78 years old. Our measurements show that most osteons possess some degree of asymmetry, and that the average degree of osteon asymmetry in cortical bone evolves with age. We then propose a comprehensive mathematical model of cortical pore filling that includes osteoblast secretory activity, osteoblast elimination, osteoblast embedment as osteocytes, and osteoblast crowding and redistribution along the bone surface. The mathematical model is first calibrated to symmetric osteon data, and then used to test three mechanisms of asymmetric wall formation against osteon data: (i) delays in the onset of infilling around the cement line; (ii) heterogeneous osteoblastogenesis around the bone perimeter; and (iii) heterogeneous osteoblast secretory rate around the bone perimeter. Our results suggest that wall thickness asymmetry due to off-centred Haversian pores within osteons, and that nonuniform lamellar thicknesses within osteons are important morphological features that can indicate the prevalence of specific asymmetry-generating mechanisms. This has significant implications for the study of disruptions of bone formation as it could indicate what biological bone formation processes may become disrupted with age or disease.

]]>
Forskning Fri, 01 Mar 2024 11:42:50 +0100 02f2ccc4-524a-4028-9c9c-02da42f62fa0
<![CDATA[Bone mineral density measurements in postmortem computed tomography]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=59214f89-8826-4fa8-b9b9-52a0cc7deb3b&tx_pure_pure5%5BshowType%5D=pub&cHash=cff0324809a700da2be8081b308ad906 Hansen, K., Vinther, D., Boel, L. W. T., et al. In quantitative postmortem computed tomography (qPMCT) the presence of putrefaction gas in tissues can obscure measurements such as bone mineral density (BMD). Quantitative CT analysis procedures adopted directly from clinical CT may not be designed to compensate for intracorporeal gas, which require additional measures for PM-imaging applications. Thus, a solid unbiased procedure for volumetric BMD analysis in PMCT of the deceased presenting with intracorporeal gas is desirable.

Materials and methods:
We tested three different analysis procedures (AP1-3) for BMD analysis of the lumbar vertebrae (L1-3). Data in this retrospective study was based on synchronous PMCT acquisition with a solid five-phase Cann-Genant phantom from routine forensic examinations of 154 individuals distributed into three putrefaction groups: “None” (n = 95), “Mild” (n = 54), and “Moderate” (n = 10). AP1 was based on commercially available software (“Mindways”), which required the operator to subjectively place region of interest (ROIs) in areas without gas. The open-source software (“FIJI”) was used for AP2 and AP3 and enabled comparison of objectively placed ROIs with AP1. In AP3, threshold-filtering was applied to remove the signal from gas (in AP2 data) prior to BMD analysis.

Results:
AP1 provided higher BMD values than AP2-3 due to subjective placement of ROIs in denser cortical areas. AP2 yielded the lowest BMD measurements with most variation, while AP3 yielded BMD measurements comparable to in vivo values published in clinical studies. AP3 provided greater interobserver correlation.

Conclusion:
AP3 provided a simple open-source software-based approach to PMCT BMD analysis that allows for precise BMD measurements in PMCT.]]>
Forskning Sat, 01 Jun 2024 11:42:50 +0200 59214f89-8826-4fa8-b9b9-52a0cc7deb3b
<![CDATA[Forensic imaging in Denmark, 20-year-experience]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=0b8723d7-4739-4be2-b011-b915db04efbf&tx_pure_pure5%5BshowType%5D=pub&cHash=ec2e6e69cb5f87f33486e41dc7caffc0 Villa, C., Larsen, S. T., Hansen, K., et al. In Denmark, post-mortem CT scanning (PMCT) was introduced over 20 years ago. The Department of Forensic Medicine, University of Copenhagen, implemented whole-body CT scanning before each autopsy in December 2002, followed by the Department at University of Southern Denmark in Odense in 2006 and at the University of Aarhus 2008. Subsequently, other equipment, including Magnetic Resonance (MR) scanners, surface scanners, photogrammetry equipment and 3D printers, were introduced in the following years. In this review, we will provide contemporary insights into the status of forensic imaging in Denmark, including requisitioned work and research. We will also discuss future directions in the field.

]]>
Forskning Fri, 01 Mar 2024 11:42:50 +0100 0b8723d7-4739-4be2-b011-b915db04efbf
<![CDATA[Homicide drop in seven European countries]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=911dea93-9c41-404a-bd0c-1000ac6537b2&tx_pure_pure5%5BshowType%5D=pub&cHash=65147e5f4e98a5352669aed72d764458 Suonpää, K., Kivivuori, J., Aarten, P., et al. This study examines homicide trends in seven European countries – Denmark, Estonia, Finland, the Netherlands, Scotland, Sweden and Switzerland – all of which manifested a substantial drop in homicide mortality between 1990 and 2016. By using data from the European Homicide Monitor, a coding scheme created to enable cross-country comparisons, combined with the national cause-of-death statistics, we explore generality versus specificity of the homicide drop. We examine changes in the demographic structure of victims and offenders and disaggregate homicides by different subtypes of lethal incidents, such as family-related homicides referring to conflicts between family members, and criminal milieu homicides occurring in the context of robberies, gang-related conflicts or organised crime. Results point to the generality of the drop: in most of the countries studied, the declining trend included all homicide types. The overall decline in homicide mortality was driven mostly by the decline in male victimisation and offending. In most of the countries, the gender distribution of victims and offenders changed only slightly during the study period, whereas the development of the distribution of homicide types manifested greater diversity. Our findings illustrate the benefits of disaggregated analyses in comparative homicide research.

]]>
Forskning Mon, 01 Jan 2024 11:42:50 +0100 911dea93-9c41-404a-bd0c-1000ac6537b2
<![CDATA[Exploring death scenes and circumstances in fatal opioid poisonings]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=9af80e11-8626-453c-96d1-8c36aae8d68b&tx_pure_pure5%5BshowType%5D=pub&cHash=14bf815de407b06a62261694a4224f59 Andersen, P. A., Thomsen, A. H., Hasselstrøm, J. B., et al. Introduction: Fatal opioid poisoning is a growing global issue. This study aims to describe circumstances surrounding fatal opioid poisonings by examining death scenes, demographics, and information from bystanders with the goal of informing prevention efforts. Methods: We extracted data from the autopsy reports of 327 forensic autopsy cases with fatal poisoning involving methadone and/or morphine from 2013–2020. Results: Fatal opioid poisonings occurred in both rural and urban areas. Death scene was the decedent's own home and a relative's or friend's home in 62% and 21%, respectively. The decedent died alone in 64% of the cases while other people were staying at the same address while death occurred in 30%. Decedents aged 15–34 years were more likely to die with other people staying at the same address than persons aged > 44 years (OR±SD: 2.3 ± 0.9, p = 0.005), and had lower postmortem blood methadone concentrations compared to persons > 34 years (Median [interquartile range]: 0.36 [0.23–0.62] vs 0.63 [0.28–1.2] mg/kg, p = 0.002). Female sex was more prevalent, and persons using illegal drugs were less prevalent in decedents aged > 44 years compared to those with age 15–44 years (29% vs 20%, p = 0.05% and 67% vs 89%, p < 0.001, respectively). Other psychoactive drugs were detected in 97% of decedents, mainly benzodiazepines (80%). Conclusions: Preventive strategies based on our findings include the need for harm reduction initiatives in both urban and rural areas, recognizing symptoms of fatal poisoning, and awareness of low tolerance among younger age groups. Urgent attention should be given to avoiding opioid use alone, particularly among older individuals, including women using prescribed opioids. Conveying the risks of polydrug use to all age groups is essential, especially co-use of sedative drugs.

]]>
Forskning Fri, 01 Mar 2024 11:42:50 +0100 9af80e11-8626-453c-96d1-8c36aae8d68b
<![CDATA[Changes in Pulmonary Vascular Resistance and Obstruction Score Following Acute Pulmonary Embolism in Pigs]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=3b886fc2-227a-40f3-a933-ab2975eff008&tx_pure_pure5%5BshowType%5D=pub&cHash=9ce875838166630364da4828226f4330 Merit, V. T., Kirk, M. E., Schultz, J. G., et al. OBJECTIVES: To investigate the contribution of mechanical obstruction and pulmonary vasoconstriction to pulmonary vascular resistance (PVR) in acute pulmonary embolism (PE) in pigs. DESIGN: Controlled, animal study. SETTING: Tertiary university hospital, animal research laboratory. SUBJECTS: Female Danish slaughter pigs (n = 12, ~60 kg). INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: PE was induced by infusion of autologous blood clots in pigs. CT pulmonary angiograms were performed at baseline, after PE (first experimental day [PEd0]) and the following 2 days (second experimental day [PEd1] and third experimental day [PEd2]), and clot burden quantified by a modified Qanadli Obstruction Score. Hemodynamics were evaluated with left and right heart catheterization and systemic invasive pressures each day before, under, and after treatment with the pulmonary vasodilators sildenafil (0.1 mg/kg) and oxygen (Fio2 40%). PE increased PVR (baseline vs. PEd0: 178 ± 54 vs. 526 ± 160 dynes; p < 0.0001) and obstruction score (baseline vs. PEd0: 0% vs. 45% ± 13%; p < 0.0001). PVR decreased toward baseline at day 1 (baseline vs. PEd1: 178 ± 54 vs. 219 ± 48; p = 0.16) and day 2 (baseline vs. PEd2: 178 ± 54 vs. 201 ± 50; p = 0.51). Obstruction score decreased only slightly at day 1 (PEd0 vs. PEd1: 45% ± 12% vs. 43% ± 14%; p = 0.04) and remained elevated throughout the study (PEd1 vs. PEd2: 43% ± 14% vs. 42% ± 17%; p = 0.74). Sildenafil and oxygen in combination decreased PVR at day 0 (–284 ± 154 dynes; p = 0.0064) but had no effects at day 1 (–8 ± 27 dynes; p = 0.4827) or day 2 (–18 ± 32 dynes; p = 0.0923). CONCLUSIONS: Pulmonary vasoconstriction, and not mechanical obstruction, was the predominant cause of increased PVR in acute PE in pigs. PVR rapidly declined over the first 2 days after onset despite a persistent mechanical obstruction of the pulmonary circulation from emboli. The findings suggest that treatment with pulmonary vasodilators might only be effective in the acute phase of PE thereby limiting the window for such therapy.

]]>
Forskning Fri, 02 Feb 2024 11:42:50 +0100 3b886fc2-227a-40f3-a933-ab2975eff008
<![CDATA[Relation of early changes of QT dispersion to changes in left ventricular systolic and diastolic function after a first acute myocardial infarction]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=a1b47525-3c5f-4b94-98f8-61caf6238137&tx_pure_pure5%5BshowType%5D=pub&cHash=cd3bb97b2c3eee7ff933777e33a6a0a8 Møller, J. E., Husic, M., Søndergaard, E., Poulsen, S. H., Egstrup, K. OBJECTIVE: To describe the relation between changes of left ventricular systolic and diastolic function and changes of QT dispersion (difference in duration between longest and shortest QT interval) following acute myocardial infarction.

DESIGN: QT dispersion was determined at admission, hospital discharge, and 1 and 3 months following myocardial infarction in 64 consecutive 1-year survivors. Patients were divided into Group A where QT dispersion was < 52 ms at all recordings or initially > 52 ms but decreased during follow-up, and Group B where QT dispersion remained increased > or = 52 ms at all measurements. Doppler-Echocardiography was carried out on day 1, day 5, and after 1, 3, and 12 months.

RESULTS: In 26 patients QT dispersion remained increased > or = 52 ms during the first 3 months after infarction. Among these a significant increase of end-systolic volume was seen whereas low or rapid normalized QT dispersion was associated with a significant decrease of ventricular volumes. After 1 year end-systolic (70 +/- 32 ml vs 49 +/- 16 ml, p = 0.006) and end-diastolic volumes (138 +/- 41 ml vs 105 +/- 22 ml, p = 0.001) were higher in Group B. In a multivariate model Group B was significantly related to an increase of end-diastolic volume (p = 0.01). In Group A diastolic function improved in eight patients and in two it deteriorated, whereas improvement was seen in one patient and deterioration in nine patients from Group B (p < 0.01).

CONCLUSION: Following myocardial infarction low QT dispersion is associated with preserved left ventricular function, whereas persistently increased dispersion is associated with left ventricular dilation and deterioration of diastolic function.

]]>
Forskning Thu, 01 Aug 2002 11:42:50 +0200 a1b47525-3c5f-4b94-98f8-61caf6238137
<![CDATA[Deaths caused by medication in persons not using illicit narcotic drugs]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=44526eac-d393-4350-bc54-c154f2207d41&tx_pure_pure5%5BshowType%5D=pub&cHash=055fbf8faa9e4b786661a43df612b539 Andersen, C. U., Ahmed, H., Rædkjær, M., Hasselstrøm, J. B., Larsen, M. K. Information regarding deaths caused by poisoning or adverse effects of medication in Danish persons not using illicit narcotic drugs (PNUIDs) is sparse. To characterize aetiology, demographics, and death scene, we reviewed all legal autopsies performed at Aarhus University from 2017 to 2019 and isolated 96 deaths caused by medications in PNUIDs. Suicides caused by medication overdose accounted for 38%. Opioids and psychotropic medications were the main cause of death in 48% and 35% of the 96 cases, respectively. Morphine, tramadol, and quetiapine were the most commonly involved individual medications. A single medication caused death in 50% of cases, and multiple substances were involved in 50%. The median total number [interquartile range] of detected medications was 5 [4–6], with a higher number in females (5 [4–7]) than males (4 [2–5]), p = 0.009. Median age was 51 [42.5–61.5] years, and 57% were female. Scene of death most frequently involved a body on a bed or couch in the decedent's own home (72%). In conclusion, opioids and psychotropic medications dominated by morphine, tramadol and quetiapine most frequently caused medication-related deaths in PNUIDs. Monitoring this type of death may yield important knowledge to direct prophylactic initiatives regarding medication use and prescription.

]]>
Forskning Sun, 01 Jan 2023 11:42:50 +0100 44526eac-d393-4350-bc54-c154f2207d41
<![CDATA[Circulating 3-hydroxy butyrate predicts mortality in patients with chronic heart failure with reduced ejection fraction]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=a14cb22a-3a56-49d2-818f-75c5c89c0d48&tx_pure_pure5%5BshowType%5D=pub&cHash=3cdfde0dbb2c821b2130abee1efd4d2c Christensen, K. H., Nielsen, R. R., Schou, M., et al. AIMS: In patients with chronic heart failure with reduced ejection fraction (HFrEF), myocardial ketone metabolism is increased and short-term treatment with the ketone body 3-hydroxy butyrate (3-OHB) has beneficial haemodynamic effects. In patients with HFrEF, we investigated whether the level of circulating 3-OHB predicted all-cause mortality and sought to identify correlations between patient characteristics and circulating 3-OHB levels.

METHODS AND RESULTS: We conducted a cohort study in 218 patients with HFrEF. Plasma 3-OHB levels were measured using high-performance liquid chromatography tandem mass spectrometry. Data on all-cause mortality were obtained by reviewing the patients' medical records, which are linked to the national 'Central Person Registry' that registers the timing of all deaths in the country. Mean left ventricular ejection fraction was 35 ± 8.6%, mean age was 67 ± 10 years, 54% were New York Heart Association II, and 27% had type 2 diabetes mellitus. Median follow-up time was 7.3 (interquartile range 6.3-8.4) years. We observed large variations in 3-OHB levels between patients (median 59 μM, range: 14-694 μM). Patients with 3-OHB levels above the median displayed a markedly increased risk of death compared with those with low levels {hazard ratio [HR]: 2.1 [95% confidence interval (CI): 1.3-3.5], P = 0.003}. In a multivariate analysis, 3-OHB predicted mortality independently of known chronic heart failure risk factors [HR: 1.004 (95% CI: 1.001-1.007), P = 0.02] and with a similar statistical strength as N-terminal pro-brain natriuretic peptide (NT-proBNP) [HR: 1.0005 (95% CI: 1.000-1.001), P = 0.02]. For every 100 μmol increase in plasma 3-OHB, the hazard of death increased by 49%. The following factors significantly predicted 3-OHB levels in the univariate analysis: free fatty acids (FFAs) [β: 238 (95% CI: 185-292), P < 0.0001], age [β: 2.43 (95% CI: 1.14-3.72), P < 0.0001], plasma insulin {β: -0.28 [95% CI: -0.54-(-0.02)], P = 0.036}, body mass index {β: -3.15 [95% CI: -5.26-(-0.05)], P = 0.046}, diabetes [β: 44.49 (95% CI: 14.84-74.14), P = 0.003], glycosylated haemoglobin [β: 1.92 (95% CI: 0.24-3.59), P = 0.025], New York Heart Association class [β: 26.86 (95% CI: 5.99-47.72), P = 0.012], and NT-proBNP [β: 0.03 (95% CI: 0.01-0.04), P = 0.001]. In a multivariate analysis, only FFAs predicted 3-OHB levels [β: 216 (95% CI: 165-268), P > 0.001].

CONCLUSIONS: In patients with HFrEF, circulating 3-OHB was a strong predictor of all-cause mortality independently of NT-proBNP. Circulating FFAs were the best predictor of 3-OHB levels.

]]>
Forskning Mon, 01 Apr 2024 11:42:50 +0200 a14cb22a-3a56-49d2-818f-75c5c89c0d48
<![CDATA[Transitory Activation and Improved Transition from Erosion to Formation within Intracortical Bone Remodeling in Hypoparathyroid Patients Treated with rhPTH(1–84)]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=53ea88ab-0229-455c-bd4a-22e6381ff747&tx_pure_pure5%5BshowType%5D=pub&cHash=4689aeecaf2e65e9b0b079ea1c6ee743 van Dijk Christiansen, P., Sikjær, T., Andreasen, C. M., et al. In hypoparathyroidism, lack of parathyroid hormone (PTH) leads to low calcium levels and decreased bone remodeling. Treatment with recombinant human PTH (rhPTH) may normalize bone turnover. This study aimed to investigate whether rhPTH(1–84) continued to activate intracortical bone remodeling after 30 months and promoted the transition from erosion to formation and whether this effect was transitory when rhPTH(1–84) was discontinued. Cortical histomorphometry was performed on 60 bone biopsies from patients (aged 31 to 78 years) with chronic hypoparathyroidism randomized to either 100 μg rhPTH(1–84) a day (n = 21) (PTH) or similar placebo (n = 21) (PLB) for 6 months as add-on to conventional therapy. This was followed by an open-label extension, where patients extended their rhPTH(1–84) (PTH) (n = 5), continued conventional treatment (CON) (n = 5), or withdrew from rhPTH(1–84) and resumed conventional therapy (PTHw) for an additional 24 months (n = 8). Bone biopsies were collected at months 6 (n = 42) and 30 (n = 18). After 6 and 30 months, the overall cortical microarchitecture (cortical porosity, thickness, pore density, and mean pore diameter) in the PTH group did not differ from that of the PLB/CON and PTHw groups. Still, the PTH group had a significantly and persistently higher percentage of pores undergoing remodeling than the PLB/CON groups. A significantly higher percentage of these pores was undergoing bone formation in the PTH compared with the PLB/CON groups, whereas the percentage of pores with erosion only was not different. This resulted in a shift in the ratio between formative and eroded pores, reflecting a faster transition from erosion to formation in the PTH-treated patients. In the rhPTH(1–84) withdrawal group PTHw, the latter effects of PTH were completely reversed in comparison to those of the PLB/CON groups. In conclusion, rhPTH(1–84) replacement therapy in hypoparathyroidism patients promotes intracortical remodeling and its transition from erosion to formation without affecting the overall cortical microstructure. The effect persists for at least 30 months and is reversible when treatment is withdrawn.

]]>
Forskning Fri, 01 Dec 2023 11:42:50 +0100 53ea88ab-0229-455c-bd4a-22e6381ff747
<![CDATA[Editorial]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=a50b7702-e6e1-47d0-b533-cf36e666f006&tx_pure_pure5%5BshowType%5D=pub&cHash=f2c28e0e569384b3c303ed31508b869a Diaz-delCastillo, M., Wilcox, G. L. Forskning Sat, 01 Jan 2022 11:42:50 +0100 a50b7702-e6e1-47d0-b533-cf36e666f006 <![CDATA[Disturbed bone marrow adiposity in patients with Cushing's syndrome and glucocorticoid- and postmenopausal- induced osteoporosis]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=7b3712b3-34f7-4029-a90c-818977ffa47d&tx_pure_pure5%5BshowType%5D=pub&cHash=7f639943b2fbefb8dee4d91cba9b0b98 Sørensen, N. N., Andreasen, C. M., Jensen, P. R., et al. BACKGROUND: Skeletal stem/progenitor cells (SSPCs) in the bone marrow can differentiate into osteoblasts or adipocytes in response to microenvironmental signalling input, including hormonal signalling. Glucocorticoids (GC) are corticosteroid hormones that promote adipogenic differentiation and are endogenously increased in patients with Cushing´s syndrome (CS). Here, we investigate bone marrow adiposity changes in response to endogenous or exogenous GC increases. For that, we characterize bone biopsies from patients with CS and post-menopausal women with glucocorticoid-induced osteoporosis (GC-O), compared to age-matched controls, including postmenopausal osteoporotic patients (PM-O).

METHODS: Transiliac crest bone biopsies from CS patients and healthy controls, and from postmenopausal women with GC-O and matched controls were analysed; an additional cohort included biopsies from women with PM-O. Plastic-embedded biopsies were sectioned for histomorphometric characterization and quantification of adipocytes. The fraction of adipocyte area per tissue (Ad.Ar/T.Ar) and marrow area (Ad.Ar/Ma.Ar), mean adipocyte profile area (Ad.Pf.Ar) and adipocyte profile density (N.Ad.Pf/Ma.Ar) were determined and correlated to steroid levels. Furthermore, the spatial distribution of adipocytes in relation to trabecular bone was characterized and correlations between bone marrow adiposity and bone remodeling parameters investigated.

RESULTS: Biopsies from patients with CS and GC-O presented increased Ad.Ar/Ma.Ar, along with adipocyte hypertrophy and hyperplasia. In patients with CS, both Ad.Ar/Ma.Ar and Ad.Pf.Ar significantly correlated with serum cortisol levels. Spatial distribution analyses revealed that, in CS, the increase in Ad.Ar/Ma.Ar near to trabecular bone (<100 µm) was mediated by both adipocyte hypertrophy and hyperplasia, while N.Ad.Pf/Ma.Ar further into the marrow (>100 µm) remained unchanged. In contrast, patients with GC-O only presented increased Ad.Ar/Ma.Ar and mean Ad.Pf.Ar>100 µm from trabecular bone surface, highlighting the differential effect of increased endogenous steroid accumulation. Finally, the Ad.Ar/Ma.Ar and Ad.Ar/T.Ar correlated with the canopy coverage above remodeling events.

CONCLUSION: Increased cortisol production in patients with CS induces increased bone marrow adiposity, primarily mediated by adipocyte hypertrophy. This adiposity is particularly evident near trabecular bone surfaces, where hyperplasia also occurs. The differential pattern of adiposity in patients with CS and GC-O highlights that bone marrow adipocytes and their progenitors may respond differently in these two GC-mediated bone diseases.

]]>
Forskning Sun, 01 Oct 2023 11:42:50 +0200 7b3712b3-34f7-4029-a90c-818977ffa47d
<![CDATA[A systematic review and meta-analysis of thigmotactic behaviour in the open field test in rodent models associated with persistent pain]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=3d8e874e-dfc8-4ed1-bd51-ca452588b8fc&tx_pure_pure5%5BshowType%5D=pub&cHash=a2913e1026acc5562c2083c88eaf3002 Zhang, X. Y., Diaz-del Castillo, M., Kong, L., et al. Thigmotaxis is an innate predator avoidance behaviour of rodents. To gain insight into how injury and disease models, and analgesic drug treatments affect thigmotaxis, we performed a systematic review and meta-analysis of studies that assessed thigmotaxis in the open field test. Systematic searches were conducted of 3 databases in October 2020, March and August 2022. Study design characteristics and experimental data were extracted and analysed using a random-effects meta-analysis. We also assessed the correlation between thigmotaxis and stimulus-evoked limb withdrawal. This review included the meta-analysis of 165 studies We report thigmotaxis was increased in injury and disease models associated with persistent pain and this increase was attenuated by analgesic drug treatments in both rat and mouse experiments. Its usefulness, however, may be limited in certain injury and disease models because our analysis suggested that thigmotaxis may be associated with the locomotor function. We also conducted subgroup analyses and meta-regression, but our findings on sources of heterogeneity are inconclusive because analyses were limited by insufficient available data. It was difficult to assess internal validity because reporting of methodological quality measures was poor, therefore, the studies have an unclear risk of bias. The correlation between time in the centre (type of a thigmotactic metric) and types of stimulus-evoked limb withdrawal was inconsistent. Therefore, stimulus-evoked and ethologically relevant behavioural paradigms should be viewed as two separate entities as they are conceptually and methodologically different from each other.

]]>
Forskning Fri, 01 Sep 2023 11:42:50 +0200 3d8e874e-dfc8-4ed1-bd51-ca452588b8fc
<![CDATA[Døden]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=95da8656-fd5a-4080-b9f4-a939c93f0d7f&tx_pure_pure5%5BshowType%5D=pub&cHash=42fa325f3339a5772e3564322642dbee Hedegård Thomsen, A. Formidling Sun, 01 Oct 2023 11:42:50 +0200 95da8656-fd5a-4080-b9f4-a939c93f0d7f <![CDATA[Novel Developments in the Treatment of Multiple Myeloma-Associated Bone Disease]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=9a8b2476-35e8-4de4-925c-68f30709ee80&tx_pure_pure5%5BshowType%5D=pub&cHash=15e874179ec2f37e7b1ed85ea7ace2e1 Johansen, M., Levring, M. B., Stokbro, K., et al. Osteolytic bone disease is present in about 80% of patients with multiple myeloma at the time of diagnosis. Managing bone disease in patients with multiple myeloma is a challenge and requires a multi-faceted treatment approach with medication, surgery, and radiation. The established treatments with intravenous or subcutaneous antiresorptives can cause debilitating adverse events for patients, mainly osteonecrosis of the jaw, which, traditionally, has been difficult to manage. Now, oral surgery is recommended and proven successful in 60–85% of patients. Patients with spinal involvement may benefit from surgery in the form of vertebroplasty and kyphoplasty for pain relief, improved mobility, and reestablished sagittal balance, as well as the restoration of vertebral height. These procedures are considered safe, but the full therapeutic impact needs to be investigated further. Ixazomib, the first oral proteasome inhibitor, increases osteoblast differentiation, and recently published preliminary results in patients treated with Ixazomib maintenance have promisingly shown increased trabecular volume caused by prolonged bone formation activity. Other novel potential treatment strategies are discussed as well.

]]>
Forskning Fri, 01 Dec 2023 11:42:50 +0100 9a8b2476-35e8-4de4-925c-68f30709ee80
<![CDATA[Pharmacokinetics and pharmacodynamics of cannabis-based medicine in a patient population included in a randomized, placebo-controlled, clinical trial]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=1d786db2-0e4b-46cc-9c8d-6c5d236474d0&tx_pure_pure5%5BshowType%5D=pub&cHash=8e94ad9a8c7c42eff8e218d653875fb7 Hansen, J. S., Boix, F., Hasselstrøm, J. B., et al. Information on the pharmacokinetics (PK) and pharmacodynamics (PD) of orally administered cannabis-based medicine (CBM) in capsule formulation in patient populations is sparse. In this exploratory study, we aimed to evaluate the PK and PD in a probable steady state of CBM in neuropathic pain and spasticity in a population of patients with multiple sclerosis (MS). Of 134 patients participating in a randomized, double-blinded, placebo-controlled, trial, 23 patients with MS (17 female) mean age 52 years (range 21-67) were enrolled in this substudy. They received oral capsules containing Δ 9 -tetrahydrocannabinol (THC, n = 4), cannabidiol (CBD, n = 6), a combination (THC&CBD, n = 4), or placebo (n = 9). Maximum doses were 22.5 mg (THC) and 45 mg (CBD) a day divided into three administrations. PD parameters were evaluated for pain and spasticity. Blood samples were analyzed using an ultra-high-performance liquid chromatography-tandem mass spectrometer after protein precipitation and phospholipid removal. PK parameters were estimated using computerized modeling. The variation in daily dose and PK between individuals was considerable in a steady state, yet comparable with previous reports from healthy controls. Based on a simulation of the best model, the estimated PK parameters (mean) for THC (5 mg) were C max 1.21 ng/mL, T max 2.68 h, and half-life 2.75 h, and for CBD (10 mg) were C max 2.67 ng/mL, T max 0.10 h, and half-life 4.95 h, respectively. No effect was found on the PD parameters, but the placebo response was considerable. More immediate adverse events were registered in the active treatment groups compared with the placebo group.

]]>
Forskning Mon, 01 Jan 2024 11:42:50 +0100 1d786db2-0e4b-46cc-9c8d-6c5d236474d0
<![CDATA[Skin lesions in 397 children referred for forensic medical examination on suspicion of physical abuse]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=1f7313c8-349b-45b3-af5a-1fedbb375a5e&tx_pure_pure5%5BshowType%5D=pub&cHash=76af690cfc3e9e62373a07a2a3934afa Frost, L., Borreschmidt, L. Q., Bindslev, D. A. Forskning Sat, 01 Jul 2023 11:42:50 +0200 1f7313c8-349b-45b3-af5a-1fedbb375a5e <![CDATA[Grauballemandens tandslid]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=bd882468-eeca-404b-b913-7468bd8b3741&tx_pure_pure5%5BshowType%5D=pub&cHash=ebfe921d8299e5124821b1d4eb01f401 Bindslev, D. A., Josephsen, K. Forskning Sun, 01 Oct 2023 11:42:50 +0200 bd882468-eeca-404b-b913-7468bd8b3741 <![CDATA[Tema: Retsodontologi]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=235dd557-8bf0-4dd9-9523-12e56d36bb12&tx_pure_pure5%5BshowType%5D=pub&cHash=4811c7c433f66fb00f7558508ed4f160 Bindslev, D. A., Fiehn, N. Formidling Tue, 01 Aug 2023 11:42:50 +0200 235dd557-8bf0-4dd9-9523-12e56d36bb12 <![CDATA[Sådan kan du effektivt hjælpe retsodontologerne i identifikationssager]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=deea2896-fc6a-4625-8315-eeb887f20685&tx_pure_pure5%5BshowType%5D=pub&cHash=cf9af942e0313ec22c38618085aa3649 Bindslev, D. A., Andreasen, K. Formidling Tue, 01 Aug 2023 11:42:50 +0200 deea2896-fc6a-4625-8315-eeb887f20685 <![CDATA[Retsodontologisk personidentifikation]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=73c968ee-238e-4fe3-ae97-8df21be165b3&tx_pure_pure5%5BshowType%5D=pub&cHash=f5f2e4d699ee2f2d66d9b725625f2239 Bindslev, D. A., Galtung, J., Lassen, J. R. Formidling Tue, 01 Aug 2023 11:42:50 +0200 73c968ee-238e-4fe3-ae97-8df21be165b3 <![CDATA[Retsodontologi]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=63d91151-88a5-4a6f-9d0a-b70b1a616b91&tx_pure_pure5%5BshowType%5D=pub&cHash=5e8cf7daff0468b11ba2464800c6936a Bindslev, D. A. Formidling Tue, 01 Aug 2023 11:42:50 +0200 63d91151-88a5-4a6f-9d0a-b70b1a616b91 <![CDATA[Material-related adverse reactions in orthodontics]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=b1978ac5-c282-45ba-aeb2-725cd87b7539&tx_pure_pure5%5BshowType%5D=pub&cHash=04e1340641872989fe1cfa094bafb207 Bindslev, D. A., Schmalz, G. Unintended direct or indirect side effects of orthodontic treatment are well recognised and quite extensively described in the literature. Since some degree of mechanically induced functional restrictions, discomfort and pain are recognised to be an experience for a major part of orthodontic patients, material-related adverse reactions (toxic/allergic) to orthodontic appliances may be misdiagnosed or go undetected. A considerable number of metals are currently used in orthodontic appliances. Some provide strength, some contribute to ‘elastic’ properties, some are added to improve the resistance to corrosion and some may be used for aesthetic reasons. Soft orthodontic removable appliances are used for different applications, for example, positioners, retainers and so-called ‘trainers’. The orthodontist and the assisting team should be aware that they are a risk group concerning possible adverse effects derived from the materials they use.

]]>
Undervisning Sat, 01 Oct 2022 11:42:50 +0200 b1978ac5-c282-45ba-aeb2-725cd87b7539
<![CDATA[Platformsforsøg]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=5e63ffdb-c549-423b-84c2-e13884f2066a&tx_pure_pure5%5BshowType%5D=pub&cHash=0612030dd239e17a31d1df3ae2e491da Perner, A., Kjær, M. B. N., Thorsen-Meyer, H. C., et al. Platform trials focus on the perpetual testing of many interventions in a disease or a setting. These trials have lasting organizational, administrative, data, analytic, and operational frameworks making them highly efficient. The use of adaptation often increases the probabilities of allocating participants to better interventions and obtaining conclusive results. The COVID-19 pandemic showed the potential of platform trials as a fast and valid way to improved treatments. This review gives an overview of key concepts and elements using the Intensive Care Platform Trial (INCEPT) as an example.

]]>
Forskning Sun, 01 Oct 2023 11:42:50 +0200 5e63ffdb-c549-423b-84c2-e13884f2066a
<![CDATA[Exploratory assessment of parental physical disease categories as predictors of documented physical child abuse]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=ace368dd-1b9c-4526-9f21-632336fe962d&tx_pure_pure5%5BshowType%5D=pub&cHash=1f6a5fdced386fad6b9d06cff964abc2 Græsholt-Knudsen, T., Rask, C. U., Lucas, S., Bech, B. H. Improved prediction of physical child abuse could aid in developing preventive measures. Parental physical disease has been tested previously as a predictor of documented physical child abuse but in broad categories and with differing results. No prior studies have tested clinically recognizable categories of parental disease in a high-powered dataset. Using Danish registries, data on children and their parents from the years 1997–2018 were used to explore several parental physical disease categories’ associations with documented physical child abuse. For each disease category, survival analysis using pseudovalues was applied. When a parent of a child was diagnosed or received medication that qualified for a category, this family and five comparison families not in this disease category were included, creating separate cohorts for each category of disease. Multiple analyses used samples drawn from 2,705,770 children. Estimates were produced for 32 categories of physical diseases. Using Bonferroni-corrected confidence intervals (CIc), ischemic heart disease showed a relative risk (RR) of 1.44 (CIc 1.13–1.84); peripheral artery occlusive disease, RR 1.39 (CIc 1.01–1.90); stroke, RR 1.19 (1.01–1.41); chronic pulmonary disease, RR 1.33 (CIc 1.18–1.51); ulcer/chronic gastritis, RR 1.27 (CIc 1.08–1.49); painful condition, 1.17 (CIc 1.00–1.37); epilepsy, RR 1.24 (CIc 1.00–1.52); and unspecific somatic symptoms, RR 1.37 (CIc 1.21–1.55). Unspecific somatic symptoms were present in 71.87% of families at some point during the study period. Conclusion: Most parental physical disease categories did not show statistically significant associations, but some showed predictive ability. Further research is needed to explore preventive potential. (Table presented.)

]]>
Forskning Thu, 01 Feb 2024 11:42:50 +0100 ace368dd-1b9c-4526-9f21-632336fe962d
<![CDATA[Bidmærkeanalyse]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=e65602cd-cf4d-4de1-84b0-40bcc3c23bc7&tx_pure_pure5%5BshowType%5D=pub&cHash=69a584cfa11af6314a0a9af255e028bb Staun Larsen, L. Formidling Tue, 01 Aug 2023 11:42:50 +0200 e65602cd-cf4d-4de1-84b0-40bcc3c23bc7 <![CDATA[3D-print as a template for reassembly of skull fragments in a homicide case]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=1a04cfb2-04bc-4c95-a0f6-ba1c5730f537&tx_pure_pure5%5BshowType%5D=pub&cHash=cdf3fd6e97c5da7dc8ba93b78ceb176b Jakobsen, S. R., Pedersen, C. C., Thomsen, A. H., Hansen, K. In this technical note we report a case where 3D-printing aided the reassembly of skull fragments in a homicide with severe tampering of the bones. A young male was shot, the body was incinerated and crushed with garden tools resulting in hundreds of brittle, calcine bone fragments from the skull. An antemortem computed tomography (CT)-scan of the skull was available from a previous assault of the victim. To aid the process of reassembly we used the antemortem CT-data to develop a 3D fixture-grid of the cranial cavity. The 3D grid was utilized as an anatomically correct template for bone reconstruction. This novel technique was based solely on open-source software including 3D Slicer and Blender and could have the potential to aid similar cases.

]]>
Forskning Wed, 01 Nov 2023 11:42:50 +0100 1a04cfb2-04bc-4c95-a0f6-ba1c5730f537
<![CDATA[Parental physical disease severity and severe documented physical child abuse]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=cf1259be-7c30-4de8-a903-3aa2a696560b&tx_pure_pure5%5BshowType%5D=pub&cHash=f378be42bb7ed7a72e5175cec2e2c001 Græsholt-Knudsen, T., Rask, C. U., Lucas, S., Obel, C., Bech, B. H. Successful prevention of physical child abuse is dependent on improvements in risk assessment. The risk of abuse is assumed to increase when family stressors overcome resources. Severe physical disease can increase stress, and parental physical disease has been studied as a risk factor for physical child abuse, but with heterogeneous definitions. This study evaluated the relation between parental physical disease severity and severe documented physical child abuse. Models were based on data on children aged 0-17 years in Denmark between 1997 and 2018, and their parents. Severe documented physical child abuse was modeled as violence against a child registered by either health authorities in treatment or mortality registries, or police authorities in cases confirmed by the courts. Parental physical disease severity was modeled as the sum of Charlson Comorbidity Index scores for the child's parents. The causal connection was examined in two model types: a survival model comparing exposed with non-exposed children, adjusted for covariates at baseline, and a G-model, taking time-varying covariates, including income and parental psychiatric disease into account. Neither model showed an association between parental physical disease severity and severe documented physical child abuse, with RR 0.99 and 95% CI (0.93-1.05) for the survival model and RR 1.08 for the G-model (CI not calculated). Conclusion: In the model studied, parental physical disease severity was not a risk factor for severe documented physical child abuse. Individual categories of physical disease remain to be examined. Trial registration: The study was pre-registered on Open Science Framework, https://osf.io/fh2sr . What is Known: • Parental physical disease severity has been studied previously as a risk indicator of physical child abuse, but based on heterogeneous definitions. • Previous studies have not studied parental physical disease severity preceding physical child abuse. What is New: • Parental severe physical disease was not prospectively associated with severe documented physical child abuse in a survival model, a G-model and a number of sensitivity analyses, respectively. • Results should be replicated in samples from populations without universal health care, and using different categories of disease.

]]>
Forskning Mon, 01 Jan 2024 11:42:50 +0100 cf1259be-7c30-4de8-a903-3aa2a696560b
<![CDATA[Distinct age-related differences among victims in cases of suspected child abuse]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=3bc24ed1-907b-4237-8f19-eb85749342f0&tx_pure_pure5%5BshowType%5D=pub&cHash=9bbadf274fadec2414e7e5e7fad0aa7d Eg, M. B., Græsholt-Knudsen, T., Madsen, K. B., Obel, C., Charles, A. V., Ingemann-Hansen, O. Evidence describing age-related differences among children with suspected physical and sexual child abuse is lacking. We describe findings in severe cases of suspected abuse. Cases with 756 children <15 years old were included during 2001–2013 at the Department of Forensic Medicine, Aarhus University, using forensic evaluation documents, medical records, and court proceedings. Eight percent of children <4 years old died from child abuse, 36% through violence resulting in death, and 64% by manslaughter, whereas 1% > 4 years old died, solely by manslaughter. External injuries were mainly located to head and torso in children <4 years old, changing to the upper and lower extremities in older children. Child sexual abuse was suspected in 52% of cases with living children <4 years old, 83% of children 4–7 years of age, 88% of children 8–11 years of age, and 93% of children >12 years old. Anogenital findings were mainly caused by other medical conditions in children <4 years old, hymenal clefts in the superior half of the hymenal rim were almost exclusively found in children between 8 and 11 years of age, whereas both superficial and complete hymenal clefts in the inferior half of the hymenal rim were found in children >12 years old. The present study describes age-related differences in victims of suspected child abuse. Fatal versus nonfatal child physical abuse and the significance of hymenal findings in child sexual abuse could be studied further.

]]>
Forskning Mon, 01 Jan 2024 11:42:50 +0100 3bc24ed1-907b-4237-8f19-eb85749342f0
<![CDATA[Combined in vivo metabolic effects of quetiapine and methadone in brain and blood of rats]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=fb979a17-2341-4fb7-b2a5-9c97e95fb24f&tx_pure_pure5%5BshowType%5D=pub&cHash=a49dabd8ffed2663baad205ee33127ac Heisel, L. S., Andersen, F. D., Joca, S., et al. Changes in pharmacokinetics and endogenous metabolites may underlie additive biological effects of concomitant use of antipsychotics and opioids. In this study, we employed untargeted metabolomics analysis and targeted analysis to examine the changes in drug metabolites and endogenous metabolites in the prefrontal cortex (PFC), midbrain, and blood of rats following acute co-administration of quetiapine and methadone. Rats were divided into four groups and received cumulative increasing doses of quetiapine (QTP), methadone (MTD), quetiapine + methadone (QTP + MTD), or vehicle (control). All samples were analyzed using liquid chromatography-mass spectrometry (LC–MS). Our findings revealed increased levels of the quetiapine metabolites: Norquetiapine, O-dealkylquetiapine, 7-hydroxyquetiapine, and quetiapine sulfoxide, in the blood and brain when methadone was present. Our study also demonstrated a decrease in methadone and its metabolite 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) in the rat brain when quetiapine was present. Despite these findings, there were only small differences in the levels of 225–296 measured endogenous metabolites due to co-administration compared to single administrations. For example, N-methylglutamic acid, glutaric acid, p-hydroxyphenyllactic acid, and corticosterone levels were significantly decreased in the brain of rats treated with both compounds. Accumulation of serotonin in the midbrain was additionally observed in the MTD group, but not in the QTP + MTD group. In conclusion, this study in rats suggests a few but important additive metabolic effects when quetiapine and methadone are co-administered.

]]>
Forskning Mon, 01 Jan 2024 11:42:50 +0100 fb979a17-2341-4fb7-b2a5-9c97e95fb24f
<![CDATA[Fatal Rupture of Occult Posttraumatic Left Ventricular Aneurysm in a Child]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=dde23df8-c3ea-46f8-913a-2a8400588f2c&tx_pure_pure5%5BshowType%5D=pub&cHash=87821f89ab334c6f290fe8c86f0b4bc6 Engholm, M., Andersen, R. F., Larsen, M. K., Jakobsen, L., Bjerre, J. V. Left ventricular aneurysm is a potentially serious but rare condition in children. This case describes delayed but fatal rupture of an occult posttraumatic left ventricular aneurysm in an 11-year-old boy with a history of blunt chest trauma from a high-impact automobile collision 7 months earlier. (Level of Difficulty: Intermediate.)

]]>
Forskning Wed, 01 Nov 2023 11:42:50 +0100 dde23df8-c3ea-46f8-913a-2a8400588f2c
<![CDATA[A porcine model of human-like chronic thromboembolic pulmonary disease]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=fb78fdf0-9b43-4f42-93f8-409a9935edf9&tx_pure_pure5%5BshowType%5D=pub&cHash=27aa8dc1eab1c898da1e6faf02cbf5cc Dragsbaek, S. J., Lyhne, M. D., Hansen, J. V., et al. Forskning Wed, 01 Nov 2023 11:42:50 +0100 fb78fdf0-9b43-4f42-93f8-409a9935edf9 <![CDATA[Osteoprogenitor recruitment and differentiation during intracortical bone remodeling of adolescent humans]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=4042ba9b-0dc8-42f4-bdae-74f8916bb341&tx_pure_pure5%5BshowType%5D=pub&cHash=15374304c933d4bc95d4820ea790920c van Dijk Christiansen, P., Andreasen, C. M., El-Masri, B. M., Laursen, K. S., Delaisse, J. M., Andersen, T. L. Background: Recruitment and proliferation of osteoprogenitors during the reversal-resorption phase, and their differentiation into mature bone-forming osteoblasts is crucial for initiation of bone formation during bone remodeling. This study investigates the osteoprogenitors' gradual recruitment, proliferation, and differentiation into bone-forming osteoblasts within intracortical remodeling events of healthy adolescent humans. Methods: The study was conducted on cortical bone specimens from 11 adolescent human controls – patients undergoing surgery due to coxa valga. The osteoprogenitor recruitment route and differentiation into osteoblasts were backtracked using immunostainings and in situ hybridizations with osteoblastic markers (CD271/NGFR, osterix/SP7, COL3A1 and COL1A1). The osteoblastic cell populations were defined based on the pore surfaces, and their proliferation index (Ki67), density and number/circumference were estimated in multiplex-immunofluorescence (Ki67, TRAcP, CD34) stained sections. Results: During the reversal-resorption phase, osteoclasts are intermixed with (COL3A1+NFGR+) osteoblastic reversal cells, which are considered to be osteoprogenitors of (COL1A1+SP7+) bone-forming osteoblasts. Initiation of bone formation requires a critical density of these osteoprogenitors (43 ± 9 cells/mm), which is reached though proliferation (4.4 ± 0.5 % proliferative) and even more so through recruitment of osteoprogenitors, but challenged by the ongoing expansion of the canal circumference. These osteoprogenitors most likely originate from osteoblastic bone lining cells and mainly lumen osteoprogenitors, which expand their population though proliferation (4.6 ± 0.3 %) and vascular recruitment. These lumen osteoprogenitors resemble canopy cells above trabecular remodeling sites, and like canopy cells they extend above bone-forming osteoblasts where they may rejuvenate the osteoblast population during bone formation. Conclusion: Initiation of bone formation during intracortical remodeling requires a critical density of osteoprogenitors on eroded surfaces, which is reached though proliferation and recruitment of local osteoprogenitors: bone lining cells and lumen osteoprogenitors.

]]>
Forskning Fri, 01 Dec 2023 11:42:50 +0100 4042ba9b-0dc8-42f4-bdae-74f8916bb341
<![CDATA[Large-Scale metabolomics]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=cec4fe68-63ea-43e6-ac67-966bfdfbe4f0&tx_pure_pure5%5BshowType%5D=pub&cHash=6d74fb57b113db9e52b308ff86b5cf3f Lassen, J. K., Wang, T., Nielsen, K. L., Hasselstrøm, J. B., Johannsen, M., Villesen, P. Untargeted metabolomics is the study of all detectable small molecules, and in geroscience, metabolomics has shown great potential to describe the biological age—a complex trait impacted by many factors. Unfortunately, the sample sizes are often insufficient to achieve sufficient power and minimize potential biases caused by, for example, demographic factors. In this study, we present the analysis of biological age in ~10,000 toxicologic routine blood measurements. The untargeted screening samples obtained from ultra-high pressure liquid chromatography-quadruple time of flight mass spectrometry (UHPLC- QTOF) cover + 300 batches and + 30 months, lack pooled quality controls, lack controlled sample collection, and has previously only been used in small-scale studies. To overcome experimental effects, we developed and tested a custom neural network model and compared it with existing prediction methods. Overall, the neural network was able to predict the chronological age with an rmse of 5.88 years (r2 = 0.63) improving upon the 6.15 years achieved by existing normalization methods. We used the feature importance algorithm, Shapley Additive exPlanations (SHAP), to identify compounds related to the biological age. Most importantly, the model returned known aging markers such as kynurenine, indole-3-aldehyde, and acylcarnitines along with a potential novel aging marker, cyclo (leu-pro). Our results validate the association of tryptophan and acylcarnitine metabolism to aging in a highly uncontrolled large-s cale sample. Also, we have shown that by using robust computational methods it is possible to deploy large LC-MS datasets for metabolomics studies to reduce the risk of bias and empower aging studies.

]]>
Forskning Mon, 01 May 2023 11:42:50 +0200 cec4fe68-63ea-43e6-ac67-966bfdfbe4f0
<![CDATA[Sex- and Lifestyle-Related Factors are Associated with Altered Hepatic CYP Protein Levels in People Diagnosed with Mental Disorders]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=5be40c9b-fa6b-4cb8-98fe-5eb17a7a225c&tx_pure_pure5%5BshowType%5D=pub&cHash=a3a47679539a380c1ae829b83439ce42 Pedersen, K. W., Hansen, J., Banner, J., Hasselstrøm, J. B., Jornil, J. R. In this study, we used human postmortem tissue to investigate hepatic protein expression levels of cytochrome P450 (CYP) 1A2, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4 by LC-MS/MS in a population of people suffering from mental disorders (n = 171). We report hepatic protein levels of these six CYP isoforms in 171 individuals in total, and define a focused population dataset of 116 individuals after excluding 55 samples due to low microsomal protein per gram of liver (MPPGL) yield. Postmortem decay was most likely the reason for the low MPPGL yield in the 55 samples. In the focused population, we found women to have significantly higher protein levels of CYP3A4 than men in addition to decreased CYP3A4 protein levels among obese individuals. Furthermore, MPPGL was negatively correlated with body mass index (BMI). An increase in CYP1A2 protein levels was observed among smokers, and increased CYP2E1 protein levels were observed among individuals with a history of alcohol abuse. Finally, individuals who received phenobarbital (CYP3A4 inducer) had significantly higher CYP3A4 levels. In conclusion, lifestyle-related factors prevalent among people suffering from mental disorders are associated with altered CYP protein levels, which may alter drug metabolism and affect the efficacy of commonly prescribed drugs. Furthermore, this investigation demonstrates that postmortem hepatic tissue can be used to study how lifestyle and effectors affect hepatic CYP-levels in a large cohort of patients. SIGNIFICANCE STATEMENT: Using a large number of postmortem hepatic tissue specimens (n=116) originating from the autopsy of individuals diagnosed with mental disorders, we were able to show that hepatic CYP-levels were affected by alcohol, smoking, BMI, and sex and that MPPGL was affected by BMI. These lifestyle-related changes may alter drug metabolism and affect the efficacy of commonly prescribed drugs. It is a novel approach to use a large postmortem cohort to investigate how lifestyle and effectors affect hepatic CYP-levels.

]]>
Forskning Fri, 01 Sep 2023 11:42:50 +0200 5be40c9b-fa6b-4cb8-98fe-5eb17a7a225c
<![CDATA[Metastatic Infiltration of Nervous Tissue and Periosteal Nerve Sprouting in Multiple Myeloma-Induced Bone Pain in Mice and Human]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=70e749c9-a253-4c26-a88d-519fee187560&tx_pure_pure5%5BshowType%5D=pub&cHash=681229af8b57080b67e714c1310f8afc Diaz-Del Castillo, M., Palasca, O., Nemler, T. T., et al. Multiple myeloma (MM) is a neoplasia of B plasma cells that often induces bone pain. However, the mechanisms underlying myeloma-induced bone pain (MIBP) are mostly unknown. Using a syngeneic MM mouse model, we show that periosteal nerve sprouting of calcitonin gene-related peptide (CGRP1) and growth associated protein 43 (GAP431) fibers occurs concurrent to the onset of nociception and its blockade provides transient pain relief. MM patient samples also showed increased periosteal innervation. Mechanistically, we investigated MM induced gene expression changes in the dorsal root ganglia (DRG) innervating the MM-bearing bone of male mice and found alterations in pathways associated with cell cycle, immune response and neuronal signaling. The MM transcriptional signature was consistent with metastatic MM infiltration to the DRG, a never-before described feature of the disease that we further demonstrated histologically. In the DRG, MM cells caused loss of vascularization and neuronal injury, which may contribute to late-stage MIBP. Interestingly, the transcriptional signature of a MM patient was consistent with MM cell infiltration to the DRG. Overall, our results suggest that MM induces a plethora of peripheral nervous system alterations that may contribute to the failure of current analgesics and suggest neuroprotective drugs as appropriate strategies to treat early onset MIBP.

]]>
Forskning Sat, 01 Jul 2023 11:42:50 +0200 70e749c9-a253-4c26-a88d-519fee187560
<![CDATA[Systematic diagnostics and documentation for whiplash]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=53e0d19c-e53a-4418-8a88-783ba02b3a39&tx_pure_pure5%5BshowType%5D=pub&cHash=69e9308f2fd0df1a1ecb6a20bd3ed8e2 Uhrenholt, L., Kasch, H., Brink, O. Whiplash injuries are common in Denmark affecting around 16,000 new patients annually. Approximately 50% of the casualties develop chronic symptoms and 10% become disabled. Many of these patients will have contact to the healthcare system, and there is a need for structured and knowledge-based examination, diagnosis and recording of findings in all clinical settings. This review discusses which variables should be recorded in clinical practice, in order to establish the best possible foundation for a structured individualized treatment protocol of the whiplash patient.

]]>
Forskning Mon, 01 May 2023 11:42:50 +0200 53e0d19c-e53a-4418-8a88-783ba02b3a39
<![CDATA[Risk of prolonged sedation with the use of chlordiazepoxide in alcohol withdrawal treatment]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=19afa3ee-763b-4a74-ac83-4fe4cfbae7d3&tx_pure_pure5%5BshowType%5D=pub&cHash=07f1c8740df210fea9feb549e6a0cfb3 Reiter, N., Andersen, C. U., Thomsen, K. L., Wamberg, C. A., Petersen, T. S., Dalhoff, K. SummaryThe use of chlordiazepoxide in the treatment of alcohol withdrawal symptoms poses a risk of prolonged sedation with the need of weeks lasting antidote treatment, and extended hospitalization due to active metabolites with very long half-lives.We present four case stories to elucidate this issue. One patient received 800 mg chlordiazepoxide and was treated with flumazenil for 42 days. Another patient was treated with 100 mg chlordiazepoxide. 5 days after administration of chlordiazepoxide, concentrations of chlordiazepoxide and its active metabolite demoxepam, were within therapeutic range, the patient was treated with flumazenil for 6 days. He died after palliative care.The great individual variation in the clinical effect of chlordiazepoxide depends on the activity of the CYP P450 system, especially CYP3A4/A5 and CYPS2C19, which can be impaired in cirrhotic and elderly patients.

]]>
Forskning Thu, 01 Jun 2023 11:42:50 +0200 19afa3ee-763b-4a74-ac83-4fe4cfbae7d3
<![CDATA[Ketone body 3-hydroxybutyrate elevates cardiac output through peripheral vasorelaxation and enhanced cardiac contractility]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=166571c3-78e3-49ec-95b8-196b78b663ca&tx_pure_pure5%5BshowType%5D=pub&cHash=2e74ac3da25b1099905e6352f9ac0208 Homilius, C., Seefeldt, J. M., Axelsen, J. B., et al. Forskning Fri, 01 Sep 2023 11:42:50 +0200 166571c3-78e3-49ec-95b8-196b78b663ca <![CDATA[Combined effects of methadone and quetiapine on respiratory rate, haemodynamic variables, and temperature in conscious rats]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=fc09cbdd-87c7-4f91-99fc-0e2225f23d7e&tx_pure_pure5%5BshowType%5D=pub&cHash=2caa13420417b449906bb2b7aca10469 Andersen, F. D., Steffensen, S. C., Vistisen, S. T., et al. Fatal poisonings where both methadone and quetiapine are detected post-mortem occurs frequently in legal autopsy cases. It is unclear whether quetiapine increases the risk of fatal methadone poisoning or if it is merely detected due to widespread use. We hypothesized that methadone and quetiapine would have additive toxic effects on respiratory rate, blood pressure, and the QTc-interval. To investigate this hypothesis, we used telemetry implants for measurements of respiratory rate, haemodynamic variables, the velocity of blood pressure changes, temperature, and movement in conscious, freely moving male Wistar rats aged 12-13 weeks. The combined effects of three accumulative i.p. doses of methadone (2.5, 10, 15 mg/kg) and quetiapine (3, 10, 30 mg/kg) were compared to rats treated with the same doses of each drug alone, and a vehicle-treated group in a randomized investigator blinded study. No additive effects of quetiapine and methadone on respiratory rate, haemodynamic variables, or movement were observed. However, body temperature was significantly lower by approximately 1.5°C on average in the group treated with both methadone and quetiapine (15 + 30 mg/kg) compared to the other groups. This indicates a synergistic effect of quetiapine and methadone on thermoregulation, which may increase the risk of fatal poisoning. We suggest studying this finding further in human settings.

]]>
Forskning Fri, 01 Sep 2023 11:42:50 +0200 fc09cbdd-87c7-4f91-99fc-0e2225f23d7e
<![CDATA[T-cell derived extracellular vesicles prime macrophages for improved STING based cancer immunotherapy]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=53555eb3-18ee-4e34-af1f-b0d871f4041f&tx_pure_pure5%5BshowType%5D=pub&cHash=6c6ba941f799e5dfb03715257dd88bb7 Hansen, A. S., Jensen, L. S., Gammelgaard, K. R., et al. A key phenomenon in cancer is the establishment of a highly immunosuppressive tumour microenvironment (TME). Despite advances in immunotherapy, where the purpose is to induce tumour recognition and hence hereof tumour eradication, the majority of patients applicable for such treatment still fail to respond. It has been suggested that high immunological activity in the tumour is essential for achieving effective response to immunotherapy, which therefore have led to exploration of strategies that triggers inflammatory pathways. Here activation of the stimulator of interferon genes (STING) signalling pathway has been considered an attractive target, as it is a potent trigger of pro-inflammatory cytokines and types I and III interferons. However, immunotherapy combined with targeted STING agonists has not yielded sustained clinical remission in humans. This suggests a need for exploring novel adjuvants to improve the innate immunological efficacy. Here, we demonstrate that extracellular vesicles (EVs), derived from activated CD4+ T cells (T-EVs), sensitizes macrophages to elevate STING activation, mediated by IFNγ carried on the T-EVs. Our work support that T-EVs can disrupt the immune suppressive environment in the tumour by reprogramming macrophages to a pro-inflammatory phenotype, and priming them for a robust immune response towards STING activation.

]]>
Forskning Tue, 01 Aug 2023 11:42:50 +0200 53555eb3-18ee-4e34-af1f-b0d871f4041f
<![CDATA[A Critical Role of the Bone Marrow Envelope in Human Bone Remodeling]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=ca66bfbb-35cb-4667-a50c-a09f577f7fd2&tx_pure_pure5%5BshowType%5D=pub&cHash=6994f7c49c70a5ec99f4eea4917803a2 Andersen, T. L., Jensen, P. R., Sikjaer, T. T., Rejnmark, L., Ejersted, C., Delaisse, J. Proper bone remodeling depends not only on a team of bone-resorbing osteoclasts and bone-forming osteoblasts. It also depends on the site-specific delivery of a large amount of osteoblast lineage cells to the bone remodeling site. How this delivery occurs is poorly known. Here, we gained insight into this mechanism by analyzing the distribution of markers of osteoblastogenesis on bone surfaces and in their bone marrow neighborhood in human cancellous bone. We found a CD271-positive/PDGFβ-R-positive cell layer surrounding the bone marrow that provides osteoblastogenic potential along all bone surfaces, whether quiescent or remodeling. This bone marrow envelope cell layer takes the appearance of a canopy above remodeling sites, where it then also shows an upregulation of the proliferation marker Ki67, smooth muscle actin (SMA), tenascin C, fibronectin, and MMP13. This indicates that the canopy is a region of the bone marrow envelope where early markers of osteoblastogenesis are activated concurrently with initiation of bone remodeling. Importantly, the high proliferation index in the canopy is not associated with increasing cell densities at the canopy level, but it is at the bone surface level, thereby supporting delivery of cells from the canopy to the bone surface. This delivery route explains why lack of canopies was previously found to coincide with lack of bone formation, and fits current knowledge on the canopies as a target for regulators of bone remodeling. We conclude that the coordination of bone marrow envelope activities and bone surface activities allows integrating osteoblastogenesis and bone remodeling into the same functional unit, and propose that the bone marrow envelope is critical for preserving bone health. © 2023 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).

]]>
Forskning Thu, 01 Jun 2023 11:42:50 +0200 ca66bfbb-35cb-4667-a50c-a09f577f7fd2
<![CDATA[Comment on: “Bone marrow embolism: should it result from traumatic bone lesions? a histopathological human autopsy study”]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=f60f0ec7-1046-4e94-9c5a-c441468a0fa7&tx_pure_pure5%5BshowType%5D=pub&cHash=b7779ca55be24db39121ea285fd1d0e3 Jakobsen, S. R., Boel, L. W. T. Forskning Sat, 01 Jul 2023 11:42:50 +0200 f60f0ec7-1046-4e94-9c5a-c441468a0fa7 <![CDATA[Kommunale tilbud og principper for substitutionsbehandling ved misbrug og afhængighed af opioider]]> https://auinstallation30.cs.au.dk/forskning/publikationer?tx_pure_pure5%5Baction%5D=single&tx_pure_pure5%5Bcontroller%5D=Publications&tx_pure_pure5%5Bid%5D=b5646e10-c02b-40db-8ef4-0bfa5f520f46&tx_pure_pure5%5BshowType%5D=pub&cHash=877eeb4f176845aa948bbf517bafd841 Mortensen, J. B., Andersen, C. U., Eriksen, T., et al. Forskning Mon, 01 May 2023 11:42:50 +0200 b5646e10-c02b-40db-8ef4-0bfa5f520f46